Publication date: 06/11/2018
PwC has entered into a strategic partnership with flanders.bio as of October 1st, 2018. Through this partnership with flanders.bio, PwC underscores its commitment of fostering innovation in life sciences in general and in Flanders in particular.
“The Flemish life sciences ecosystem is thriving - it employs over 30,000 highly skilled people, and all the world’s top biopharma players have key activities in Belgium,” states Peter Opsomer, Partner, PwC Belgium. “The sector is a dense community of agile SMEs and top-notch academic institutions, research parks, incubators, hospitals and clinical research organisations. Both PwC and flanders.bio are deeply committed to playing an active role in helping it continue to flourish; our strategic partnership paves the way for us to contribute to its further growth together.”
“We are very pleased with this new strategic partnership for flanders.bio. It will further expand the range of expertise we are building to support our members in the different phases of their lifecycle from start-up to scale-up and beyond. Over the past years, flanders.bio has moved from a pioneering role representing, promoting and connecting biotechnology companies to a more content driven organisation and key player in the life sciences ecosystem. As such our strategic partnerships are also essential in the development of our long-term strategic vision to further strengthen the life sciences ecosystem in Flanders,” adds Pascale Engelen, Co-General Manager of flanders.bio.
“Belgium already represents 16% of the revenue and almost 10% of the R&D expenditure in the European biotech sector. Most Belgian biotech companies have activities outside Belgium, and there has always been a strong correlation between growth and internationalisation in the sector,” explains Didier Delanoye, Partner, PwC Belgium. “The combination of our multidisciplinary approach and our experience in supporting organisations in cross-border expansion makes PwC an ideal partner for high potential start-ups and scale-ups. We stand by them at all stages of their life cycle, helping them with key decisions, tax and compliance questions, organisation and reporting, deals, business plans and more - we’re on board from the beginning, for the long run.”
At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 158 countries with more than 250,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.
PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity.
Please see www.pwc.com/structure for further details.
flanders.bio is a dynamic, member driven organisation with currently more than 350 members from Belgium and abroad. We help our members to create value by organising Networking and Training Activities, supporting Internationalisation, providing Services and building Expertise.
flanders.bio and its members want to be the proud advocates of a reputable global-impact ecosystem in life sciences.
flanders.bio is supported by a number of strategic partners: CMAST, Flanders Investment & Trade, Gimv, Janssen Pharmaceutica, KBC Securities, PwC, VIB and Agentschap Innoveren & Ondernemen.
For more info, please visit www.flanders.bio.